Work

Phase II study of PKC-α antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer

Year: 2006

Type: article

Study design: Clinical Trial

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2005.12.012

Authors: Paul Ritch, Charles M. Rudin, Jacob David Bitran, Martin J. Edelman, Alex Makalinao, David Irwin, Rogerio Lilenbaum, Patrick Peterson, William J. John

Institutions: University of Chicago Medical Center, Advocate Lutheran General Hospital, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Alta Bates Summit Medical Center, Mount Sinai Medical Center, Eli Lilly (United States), Commonwealth Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2016765784

FWCI: 2.682

Cites: 29

Cited by: 37

Related to: 10